Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Type	Shares Traded	Price
May 18, 2022	MURPHY ANDREW J EVP Research	EVP Research	Other acquisition or disposition	--	--
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Open market or private sale of non-derivative or derivative security	59	$655.40
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Open market or private sale of non-derivative or derivative security	58	$656.52
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Open market or private sale of non-derivative or derivative security	60	$657.51
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Open market or private sale of non-derivative or derivative security	123	$658.56
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Open market or private sale of non-derivative or derivative security	77	$660.32
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Open market or private sale of non-derivative or derivative security	465	$661.46
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Open market or private sale of non-derivative or derivative security	779	$662.57
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Open market or private sale of non-derivative or derivative security	472	$663.60
May 17, 2022	MURPHY ANDREW J EVP Research	EVP Research	Open market or private sale of non-derivative or derivative security	428	$664.32

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media